Last quarter (Q0 0), GRI Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, GRI Bio's net income was $-2.12M. See GRI Bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ 100.00K	$ 0.00
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 12.22M	$ 11.39M	$ 2.24M	$ 9.26M	$ 4.89M	$ 3.15M
Operating Income	$ -12.22M	$ -11.39M	$ -2.24M	$ -9.26M	$ -4.79M	$ -3.15M
Net Non Operating Interest Income Expense	$ -915.00K	$ -2.08M	$ 653.00K	$ -16.00K	$ -34.00K	$ -197.00K
Other Income Expense	$ ―	$ 432.00K	$ -325.00K	$ 28.00K	$ ―	$ -113.00K
Pretax Income	$ -13.13M	$ -13.04M	$ -3.22M	$ -9.30M	$ -4.82M	$ -3.46M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -13.01M	$ -13.04M	$ -3.22M	$ -9.30M	$ -4.82M	$ -3.46M
Basic EPS	$ -265.47	$ -367.37	$ -0.69	$ -1.42	$ -0.78	$ -0.60
Diluted EPS	$ -265.47	$ -367.37	$ -0.69	$ -1.42	$ -0.78	$ -0.60
Basic Average Shares	$ 3.96M	$ 35.51K	$ 10.14M	$ 6.54M	$ 6.76M	$ 5.80M
Diluted Average Shares	$ 3.96M	$ 35.51K	$ 10.14M	$ 6.54M	$ 6.76M	$ 5.80M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 12.22M	$ 11.39M	$ 2.24M	$ 9.26M	$ 4.89M	$ 3.15M
Net Income From Continuing And Discontinued Operation	$ -13.01M	$ -13.04M	$ -3.22M	$ -9.30M	$ -4.82M	$ -3.46M
Normalized Income	$ -6.20M	$ ―	$ ―	$ ―	$ -4.82M	$ -3.35M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ 34.00K	$ 197.00K
EBIT	$ -13.02M	$ -10.96M	$ -2.56M	$ -9.30M	$ -4.79M	$ -3.27M
EBITDA	$ -12.04M	$ -8.79M	$ -2.56M	$ -9.20M	$ -4.71M	$ -3.25M

Currency in USD

GRI Bio Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing